J7640 HCPCS Level II code: Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms
J7640 is the HCPCS code for “Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J7640Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms
Short description: Formoterol comp unit
HCPCS · United States
Medicare details
The indicators CMS publishes with J7640 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Drugs Administered through DME
- Added
- Jan 1, 2006
Where J7640 sits
- 1J codesDrugs administered other than orally
- 2Active code J7640Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J7640 mean?
J7640 is the HCPCS code for “Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J7640?
CMS lists J7640’s Medicare coverage as “Carrier judgment” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7640
All J codesJ7634Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligramJ7635Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligramJ7636Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligramJ7637Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligramJ7638Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligramJ7639Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligramJ7641Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligramJ7642Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligramJ7643Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligramJ7644Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligramJ7645Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligramJ7647Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram